Veracyte, Inc. (VCYT) Stock Analysis

Veracyte, Inc. (VCYT) Stock Analysis — AI Research | MarketCI

VCYT

Market Closed

Veracyte, Inc.

NASDAQHealthcare Biotechnology

824 employees

CEO: Marc A. Stapley

Founded: 2013

$47.33

+$0.00(+NaN%)

Market Cap

3.78B

Beta

1.98

52W Range

N/A

Dividend Yield

0.00%

Overview Forecasts Fundamental Market Sentiment Valuation Ownership

VCYT Price Chart

Historical price performance

Loading MCI price data...

MarketCI Investment Signals

AI-synthesized investment signal for VCYT built from valuation, fundamentals, sentiment, and risk models

Investment Signal

Hold

Pass %

57.14%

Score

4/7

Fair Value Estimate

Cash flow analysis • Multiple methods

$38.57

AI Price Target

Machine learning • Price prediction

$44.26

Market Sentiment

News & social media analysis

0.00

Value Investor Price

Classic value analysis

$11.72

Financial Health

Bankruptcy risk assessment

25.20

Quality Score

Financial strength rating

7.00

AI Investment Grade

Deep analysis of filings & news

75.00

Key Investment Highlights

Important factors affecting VCYT investment thesis

Due Diligence Analysis

Investment criteria assessment and scoring

Overall Assessment

70.00% Good

Conditions Met

28.00/40.00

Due Diligence Score

70.00%

Due Diligence Conditions

Investment analysis conditions and results


	Pass
	Fail
	Pass
	Pass
	Pass
	Pass

Showing 1 to 6 of 46 conditions